PL3759113T3 - Pochodne 10-(di(fenylo)metylo)-4-hydroksy-8,9,9a,10-tetrahydro-7h- pirolo[1’,2’:4,5]pirazyno[1,2-b]pirydazyno-3,5-dionowe i związki pokrewne jako inhibitory replikacji ortomyksowirusów do leczenia grypy - Google Patents
Pochodne 10-(di(fenylo)metylo)-4-hydroksy-8,9,9a,10-tetrahydro-7h- pirolo[1’,2’:4,5]pirazyno[1,2-b]pirydazyno-3,5-dionowe i związki pokrewne jako inhibitory replikacji ortomyksowirusów do leczenia grypyInfo
- Publication number
- PL3759113T3 PL3759113T3 PL19713572.6T PL19713572T PL3759113T3 PL 3759113 T3 PL3759113 T3 PL 3759113T3 PL 19713572 T PL19713572 T PL 19713572T PL 3759113 T3 PL3759113 T3 PL 3759113T3
- Authority
- PL
- Poland
- Prior art keywords
- pyrrollo
- pyrazino
- pyridazine
- influenza
- tetrahydro
- Prior art date
Links
- YXKFWFPIHMMZAG-UHFFFAOYSA-N 1h-pyridazine-4,6-dione Chemical class O=C1CC(=O)C=NN1 YXKFWFPIHMMZAG-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 206010022000 influenza Diseases 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000010076 replication Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862636378P | 2018-02-28 | 2018-02-28 | |
| PCT/IB2019/051549 WO2019166950A1 (en) | 2018-02-28 | 2019-02-26 | 10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7h-pyrrolo[1 ',2':4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3759113T3 true PL3759113T3 (pl) | 2025-01-20 |
Family
ID=65911219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19713572.6T PL3759113T3 (pl) | 2018-02-28 | 2019-02-26 | Pochodne 10-(di(fenylo)metylo)-4-hydroksy-8,9,9a,10-tetrahydro-7h- pirolo[1’,2’:4,5]pirazyno[1,2-b]pirydazyno-3,5-dionowe i związki pokrewne jako inhibitory replikacji ortomyksowirusów do leczenia grypy |
Country Status (31)
| Country | Link |
|---|---|
| US (3) | US11629149B2 (pl) |
| EP (2) | EP4467198A3 (pl) |
| JP (4) | JP7065989B2 (pl) |
| KR (3) | KR102521320B1 (pl) |
| CN (2) | CN111801333B (pl) |
| AU (1) | AU2019227250B2 (pl) |
| BR (1) | BR112020017121A2 (pl) |
| CA (1) | CA3092544A1 (pl) |
| CL (1) | CL2020002202A1 (pl) |
| CR (2) | CR20200372A (pl) |
| DK (1) | DK3759113T3 (pl) |
| EA (1) | EA202091696A1 (pl) |
| ES (1) | ES2993277T3 (pl) |
| FI (1) | FI3759113T3 (pl) |
| HR (1) | HRP20241522T1 (pl) |
| HU (1) | HUE069183T2 (pl) |
| IL (3) | IL276901B2 (pl) |
| LT (1) | LT3759113T (pl) |
| MX (2) | MX2020008959A (pl) |
| MY (1) | MY203207A (pl) |
| NZ (1) | NZ767072A (pl) |
| PE (1) | PE20210403A1 (pl) |
| PH (1) | PH12020500660A1 (pl) |
| PL (1) | PL3759113T3 (pl) |
| PT (1) | PT3759113T (pl) |
| SA (1) | SA520420046B1 (pl) |
| SG (1) | SG11202007718SA (pl) |
| SI (1) | SI3759113T1 (pl) |
| UA (1) | UA126253C2 (pl) |
| WO (1) | WO2019166950A1 (pl) |
| ZA (1) | ZA202005507B (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2881776T3 (es) | 2016-03-08 | 2021-11-30 | Novartis Ag | Compuestos tricíclicos útiles para tratar las infecciones por ortomixovirus |
| JOP20170169A1 (ar) | 2016-08-29 | 2019-01-30 | Novartis Ag | مركبات بيريدازين ثلاثية الحلقة مندمجة تفيد في علاج العدوى بفيروس أورثوميكسو |
| HUE069183T2 (hu) * | 2018-02-28 | 2025-02-28 | Novartis Ag | 10-(di(fenil)metil)-4-hidroxi-8,9,9a,10-tetrahidro-7H--pirrolo[1',2':4,5]pirazino[1,2-b]piridazin-3,5-dion származékok és kapcsolódó vegyületek mint orthomyxovírus repikáció gátlók influenza kezelésére |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2225112A (en) | 1938-07-09 | 1940-12-17 | Wright Aeronautical Corp | Air cleaner |
| GB8501542D0 (en) | 1985-01-22 | 1985-02-20 | Erba Farmitalia | 4 5 6 7-tetrahydro-imidazo(4 5-clpyridine derivatives |
| AUPM354694A0 (en) | 1994-01-27 | 1994-02-17 | Biota Scientific Management Pty Ltd | Chemical compounds |
| ATE530520T1 (de) | 2001-08-10 | 2011-11-15 | Shionogi & Co | Antivirales mittel |
| WO2004078163A2 (en) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| TW200510425A (en) | 2003-08-13 | 2005-03-16 | Japan Tobacco Inc | Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor |
| TW200526635A (en) | 2003-12-22 | 2005-08-16 | Shionogi & Co | Hydroxypyrimidinone derivative having HIV integrase inhibitory activity |
| AU2005221864A1 (en) | 2004-03-09 | 2005-09-22 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa | HIV integrase inhibitors |
| FR2901795A1 (fr) | 2006-05-30 | 2007-12-07 | Fourtillan Snc | Derives de pyrimidino[1',6'-1,2]pyrido[3,4-b]indoles et leur utilisation en therapeutique |
| EA019520B1 (ru) | 2008-10-31 | 2014-04-30 | Сионоги Энд Ко., Лтд. | Цефалоспорины, содержащие катехольную группу |
| TWI518084B (zh) | 2009-03-26 | 2016-01-21 | 鹽野義製藥股份有限公司 | 哌喃酮與吡啶酮衍生物之製造方法 |
| US8835461B2 (en) | 2009-03-26 | 2014-09-16 | Shionogi & Co., Ltd. | Substituted 3-hydroxy-4-pyridone derivative |
| JP5737691B2 (ja) * | 2009-06-15 | 2015-06-17 | 塩野義製薬株式会社 | 置換された多環性カルバモイルピリドン誘導体 |
| CN102762568A (zh) | 2009-12-23 | 2012-10-31 | 伊兰药品公司 | 作为polo样激酶的抑制剂的蝶啶酮 |
| TW201201813A (en) | 2010-03-31 | 2012-01-16 | Arqule Inc | Substituted benzo-pyrido-triazolo-diazepine compounds |
| US20120195857A1 (en) | 2010-08-12 | 2012-08-02 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
| LT2620436T (lt) | 2010-09-24 | 2018-08-10 | Shionogi & Co., Ltd. | Pakeistojo policiklinio karbamoilpiridono darinio provaistas |
| WO2012151567A1 (en) | 2011-05-05 | 2012-11-08 | St. Jude Children's Research Hospital | Pyrimidinone compounds and methods for preventing and treating influenza |
| AU2012321762A1 (en) | 2011-10-12 | 2014-04-17 | Shionogi & Co., Ltd. | Polycyclic pyridone derivative having integrase-inhibiting activity |
| US9278996B2 (en) | 2012-09-20 | 2016-03-08 | Celltrion, Inc. | Dolastatin-10 derivative, method of producing the same and anticancer drug composition containing the same |
| EA201591291A1 (ru) | 2013-01-08 | 2015-12-30 | Савира Фармасьютикалз Гмбх | Производные пиримидона и их применение в лечении, облегчении или профилактике вирусного заболевания |
| CA2921294C (en) | 2013-08-21 | 2023-05-16 | Alios Biopharma, Inc. | Antiviral compounds |
| CN105530946A (zh) | 2013-09-11 | 2016-04-27 | 南加利福尼亚大学 | 具有高度表达的fas配体的干细胞组合物 |
| CN105764904B (zh) | 2013-09-12 | 2020-02-11 | 詹森生物制药有限公司 | 氮杂-吡啶酮化合物及其用途 |
| AU2014318837B2 (en) | 2013-09-12 | 2019-05-30 | Janssen Biopharma, Inc. | Pyridazinone compounds and uses thereof |
| CA2953862A1 (en) | 2014-07-07 | 2016-01-14 | F. Hoffmann-La Roche Ag | Dihydropyridopyrazine-1,8-diones and their use in the treatment, amelioration or prevention of viral diseases |
| WO2016145103A1 (en) * | 2015-03-11 | 2016-09-15 | Alios Biopharma, Inc. | Aza-pyridone compounds and uses thereof |
| ES2881776T3 (es) | 2016-03-08 | 2021-11-30 | Novartis Ag | Compuestos tricíclicos útiles para tratar las infecciones por ortomixovirus |
| WO2017156407A1 (en) | 2016-03-10 | 2017-09-14 | Alios Biopharma, Inc. | Method of preparing aza-pyridone compounds |
| WO2018005863A1 (en) | 2016-07-01 | 2018-01-04 | G1 Therapeutics, Inc. | Pyrimidine-based compounds for the treatment of cancer |
| CN109789143A (zh) | 2016-07-01 | 2019-05-21 | G1治疗公司 | 基于嘧啶的抗增殖剂 |
| US10759814B2 (en) * | 2016-08-10 | 2020-09-01 | Shionogi & Co., Ltd. | Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof |
| JOP20170169A1 (ar) * | 2016-08-29 | 2019-01-30 | Novartis Ag | مركبات بيريدازين ثلاثية الحلقة مندمجة تفيد في علاج العدوى بفيروس أورثوميكسو |
| JP2019059697A (ja) | 2017-09-28 | 2019-04-18 | 塩野義製薬株式会社 | 置換された多環性ピリダジン誘導体およびそのプロドラッグ |
| CN110041327B (zh) * | 2018-01-17 | 2022-01-21 | 江西彩石医药科技有限公司 | 吡啶酮衍生物、其组合物及作为抗流感病毒药物的应用 |
| CN111848615B (zh) | 2018-01-17 | 2022-05-17 | 江西彩石医药科技有限公司 | 吡啶酮衍生物及包含其的抗流感病毒药物组合物 |
| KR20200126973A (ko) | 2018-02-28 | 2020-11-09 | 니뽄 다바코 산교 가부시키가이샤 | 4-메틸디히드로피리미디논 화합물 및 그의 의약 용도 |
| PE20211456A1 (es) | 2018-02-28 | 2021-08-05 | Hoffmann La Roche | Compuestos de sulfonimidoilpurinona 7-sustituidos y sus derivados para el tratamiento y prevencion del cancer de higado |
| CN111741948B (zh) | 2018-02-28 | 2023-11-10 | 日本烟草产业株式会社 | 饱和环稠合的二氢嘧啶酮或二氢三嗪酮化合物及其药物用途 |
| HUE069183T2 (hu) | 2018-02-28 | 2025-02-28 | Novartis Ag | 10-(di(fenil)metil)-4-hidroxi-8,9,9a,10-tetrahidro-7H--pirrolo[1',2':4,5]pirazino[1,2-b]piridazin-3,5-dion származékok és kapcsolódó vegyületek mint orthomyxovírus repikáció gátlók influenza kezelésére |
-
2019
- 2019-02-26 HU HUE19713572A patent/HUE069183T2/hu unknown
- 2019-02-26 WO PCT/IB2019/051549 patent/WO2019166950A1/en not_active Ceased
- 2019-02-26 KR KR1020207027420A patent/KR102521320B1/ko active Active
- 2019-02-26 MX MX2020008959A patent/MX2020008959A/es unknown
- 2019-02-26 EP EP24195375.1A patent/EP4467198A3/en active Pending
- 2019-02-26 IL IL276901A patent/IL276901B2/en unknown
- 2019-02-26 CA CA3092544A patent/CA3092544A1/en active Pending
- 2019-02-26 CN CN201980015931.XA patent/CN111801333B/zh active Active
- 2019-02-26 EP EP19713572.6A patent/EP3759113B1/en active Active
- 2019-02-26 MY MYPI2020004423A patent/MY203207A/en unknown
- 2019-02-26 KR KR1020237006152A patent/KR20230031990A/ko not_active Ceased
- 2019-02-26 CN CN202410938055.0A patent/CN118878544A/zh active Pending
- 2019-02-26 BR BR112020017121-2A patent/BR112020017121A2/pt active Search and Examination
- 2019-02-26 JP JP2020544932A patent/JP7065989B2/ja active Active
- 2019-02-26 CR CR20200372A patent/CR20200372A/es unknown
- 2019-02-26 PE PE2020001286A patent/PE20210403A1/es unknown
- 2019-02-26 NZ NZ767072A patent/NZ767072A/en unknown
- 2019-02-26 FI FIEP19713572.6T patent/FI3759113T3/fi active
- 2019-02-26 EA EA202091696A patent/EA202091696A1/ru unknown
- 2019-02-26 DK DK19713572.6T patent/DK3759113T3/da active
- 2019-02-26 HR HRP20241522TT patent/HRP20241522T1/hr unknown
- 2019-02-26 UA UAA202005624A patent/UA126253C2/uk unknown
- 2019-02-26 ES ES19713572T patent/ES2993277T3/es active Active
- 2019-02-26 US US16/975,784 patent/US11629149B2/en active Active
- 2019-02-26 PT PT197135726T patent/PT3759113T/pt unknown
- 2019-02-26 CR CR20240350A patent/CR20240350A/es unknown
- 2019-02-26 PL PL19713572.6T patent/PL3759113T3/pl unknown
- 2019-02-26 LT LTEPPCT/IB2019/051549T patent/LT3759113T/lt unknown
- 2019-02-26 IL IL326515A patent/IL326515A/en unknown
- 2019-02-26 SG SG11202007718SA patent/SG11202007718SA/en unknown
- 2019-02-26 AU AU2019227250A patent/AU2019227250B2/en active Active
- 2019-02-26 SI SI201930859T patent/SI3759113T1/sl unknown
- 2019-02-26 KR KR1020247015694A patent/KR20240073143A/ko active Pending
-
2020
- 2020-08-26 SA SA520420046A patent/SA520420046B1/ar unknown
- 2020-08-26 CL CL2020002202A patent/CL2020002202A1/es unknown
- 2020-08-27 MX MX2023000084A patent/MX2023000084A/es unknown
- 2020-08-27 PH PH12020500660A patent/PH12020500660A1/en unknown
- 2020-09-03 ZA ZA2020/05507A patent/ZA202005507B/en unknown
-
2022
- 2022-02-04 JP JP2022016352A patent/JP2022048391A/ja not_active Withdrawn
-
2023
- 2023-02-27 US US18/114,336 patent/US12071441B2/en active Active
- 2023-09-14 IL IL305957A patent/IL305957B2/en unknown
-
2024
- 2024-02-05 JP JP2024016007A patent/JP2024033009A/ja not_active Withdrawn
- 2024-07-03 US US18/764,058 patent/US20250034156A1/en active Pending
-
2025
- 2025-12-11 JP JP2025245272A patent/JP2026034569A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020014245A (es) | Inhibidores de quinasas dependientes de ciclinas. | |
| GEP20217248B (en) | 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh | |
| CY1122046T1 (el) | Δικυκλικα ετεροκυκλικα παραγωγα ως αναστολεις βρομοτομεων | |
| MX2019015431A (es) | Compuesto cíclico tipo cumarina como inhibidor de mek y su uso. | |
| MX388533B (es) | Compuestos de benzoxacepina oxazolidinona y métodos de uso. | |
| CL2008002131A1 (es) | Compuestos heterociclos de amidas derivados de pirimidinas sustituidas por heterociclos y heterobiciclicos, inhibidores de la proteincinasa; composicion farmaceutica; y uso de los compuestos en el tratamiento de enfermedades proliferativas, neurologicas o neurodegenerativas, cardiovasculares, virosica o fungicas. | |
| IL283823A (en) | 7-phenoxy-n-(3-azabicyclo[3.2.1]octan-8-yl)-6,7-dihydro-5h-pyrrolo[1,2-b][1,2,4]triazol-2-amine derivatives and related compounds as gamma-secretase modulators for the treatment of alzheimer's disease | |
| GEAP202215303A (en) | Chromane monobactam compounds for the treatment of bacterial infections | |
| PL3986561T3 (pl) | Pochodne pirydo[2,3-d]pirymidyny jako inhibitory replikacji ludzkiego wirusa niedoboru odporności | |
| DK3873884T3 (da) | 3-(quinolin-8-yl)-1,4-dihydropyrido[3,4-d]pyrimidin-2,4-dion-derivater som alpha4beta7-integrinhæmmere til behandling af inflammatoriske sygdomme | |
| WO2010068483A3 (en) | Mlk inhibitors and methods of use | |
| EA200900798A1 (ru) | Производные индол-4-илпиримидинил-2-иламина и их применение в качестве ингибиторов циклинзависимой киназы | |
| CL2007002166A1 (es) | Compuestos derivados de heterociclos de nitrogeno, antagonistas de los inhibidores de las proteinas de la apoptosis; sus composiciones farmaceuticas; y uso de dichos compuestos para el tratamiento del cancer. | |
| MX381994B (es) | Inhibidor de janus quinasa. | |
| BR112016015838A8 (pt) | compostos heterocíclicos aromáticos, composição farmacêutica compreendendo os referidos compostos e produto de combinação | |
| IL276901A (en) | History of 10-(di(phenyl)methyl)-4-hydroxy-8,9,10,9A-tetrahydro-H7-pyrrolo[1',2':4,5]pyrazino[1,2-B]pyridazine-3 5-Dion and related compounds as inhibitors of orthomyxovirus replication for the treatment of influenza | |
| CR20210666A (es) | Derivados heterocíclicos condensados | |
| EA201692557A1 (ru) | Хинолизиноновые производные в качестве ингибиторов pi3k | |
| ATE546452T1 (de) | Pyrazolopyrrolderivate als proteinkinaseinhibitoren | |
| EA201991355A1 (ru) | Производные имидазо[1,5-а]пиразина в качестве ингибиторов pi3kдельта | |
| EP3849987C0 (en) | (S)-2-(4-(PHENYL)-6H-THIENO[3,2-F][1,2,4]TRIAZOLO[4,3-A] [1,4]DIAZEPIN-6 ACETATE DERIVATIVES -YL) TERT-BUTYL AND SIMILAR COMPOUNDS AS BRD4 BROMODOMAIN INHIBITORS FOR THE TREATMENT OF CANCER | |
| BR112016005000A8 (pt) | combinação, kit de combinação, uso de uma combinação, composição farmacêutica, e, composto | |
| PL408801A1 (pl) | Nowe 5-arylo-7-metylo-5H-pirazolo[4,3-e]tetrazolo[4,5-b][1,2,4]triazyny | |
| EA202090644A1 (ru) | ПРОИЗВОДНЫЕ ИМИДАЗО[1,5-a]ПИРАЗИНА КАК ИНГИБИТОРЫ PI3K | |
| BR112016022974A2 (pt) | derivados de 2,4-tiazolidinadiona no tratamento de distúrbios do sistema nervoso central |